162 related articles for article (PubMed ID: 26348484)
41. Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn.
Arima T; Uchiyama M; Nakano Y; Nagasaka S; Kang D; Shimizu A; Takahashi H
Sci Rep; 2017 Dec; 7(1):17763. PubMed ID: 29259285
[TBL] [Abstract][Full Text] [Related]
42. Persimmon Leaves (Diospyros kaki) Extract Protects Optic Nerve Crush-Induced Retinal Degeneration.
Ryul Ahn H; Kim KA; Kang SW; Lee JY; Kim TJ; Jung SH
Sci Rep; 2017 Apr; 7():46449. PubMed ID: 28425487
[TBL] [Abstract][Full Text] [Related]
43. Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization.
Lee CM; Jung WK; Na G; Lee DS; Park SG; Seo SK; Yang JW; Yea SS; Lee YM; Park WS; Choi IW
Cutan Ocul Toxicol; 2015 Mar; 34(1):53-60. PubMed ID: 24754407
[TBL] [Abstract][Full Text] [Related]
44. Persimmon Leaves (
Afzal R; Hwang HB
Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056129
[TBL] [Abstract][Full Text] [Related]
45. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo.
Bian F; Zhang MC; Zhu Y
Ophthalmologica; 2008; 222(3):178-86. PubMed ID: 18497527
[TBL] [Abstract][Full Text] [Related]
46. The wound healing effects of vitamin A eye drops after a corneal alkali burn in rats.
Kim EC; Kim TK; Park SH; Kim MS
Acta Ophthalmol; 2012 Nov; 90(7):e540-6. PubMed ID: 23106861
[TBL] [Abstract][Full Text] [Related]
47. Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.
Yoeruek E; Ziemssen F; Henke-Fahle S; Tatar O; Tura A; Grisanti S; Bartz-Schmidt KU; Szurman P;
Acta Ophthalmol; 2008 May; 86(3):322-8. PubMed ID: 17995975
[TBL] [Abstract][Full Text] [Related]
48. [Effects of flavone from leaves of Diospyros kaki on expression of apoptosis signal-regulating kinase 1 and rat vascular smooth muscle cells proliferation by tumor necrosis factor alpha in vitro].
Ouyancg P; Zhang B; Bei WJ; Lai WY; Peng WL; Xu DL
Zhong Yao Cai; 2007 Jul; 30(7):819-22. PubMed ID: 17944194
[TBL] [Abstract][Full Text] [Related]
49. The Intraocular Pressure-Lowering Effect of Persimmon leaves (
Ahn HR; Yang JW; Kim JY; Lee CY; Kim TJ; Jung SH
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652855
[TBL] [Abstract][Full Text] [Related]
50. Effects of lapatinib and trastuzumab on vascular endothelial growth factor in experimental corneal neovascularization.
Kaya MK; Demir T; Bulut H; Akpolat N; Turgut B
Clin Exp Ophthalmol; 2015 Jul; 43(5):449-57. PubMed ID: 25640924
[TBL] [Abstract][Full Text] [Related]
51. URP20 improves corneal injury caused by alkali burns combined with pathogenic bacterial infection in rats.
Gong Y; Gao J; Li M; Zhang XL; Liao YH; Bao YB
Exp Eye Res; 2024 Jan; 238():109739. PubMed ID: 38042515
[TBL] [Abstract][Full Text] [Related]
52. Subconjunctival injection of recombinant AAV-angiostatin ameliorates alkali burn induced corneal angiogenesis.
Cheng HC; Yeh SI; Tsao YP; Kuo PC
Mol Vis; 2007 Dec; 13():2344-52. PubMed ID: 18199977
[TBL] [Abstract][Full Text] [Related]
53. Anti-angiogenic effect of KR-31831 on corneal and choroidal neovascularization in rat models.
Kim IT; Park HY; Choi JS; Joo CK
Invest Ophthalmol Vis Sci; 2012 May; 53(6):3111-9. PubMed ID: 22491414
[TBL] [Abstract][Full Text] [Related]
54. Critical role of TNF-α-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization.
Lu P; Li L; Liu G; Baba T; Ishida Y; Nosaka M; Kondo T; Zhang X; Mukaida N
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3516-26. PubMed ID: 22570350
[TBL] [Abstract][Full Text] [Related]
55. [Study on the rat models of corneal neovascularization induced by alkali burn].
Yan S; Liang D; Lin M; Li Y; Wang Z
Yan Ke Xue Bao; 2005 Dec; 21(4):165-9, 172. PubMed ID: 17162875
[TBL] [Abstract][Full Text] [Related]
56. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist.
Lu P; Li L; Liu G; Zhang X; Mukaida N
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4761-8. PubMed ID: 19458323
[TBL] [Abstract][Full Text] [Related]
57. NK1 receptor antagonists as a new treatment for corneal neovascularization.
Bignami F; Giacomini C; Lorusso A; Aramini A; Rama P; Ferrari G
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6783-94. PubMed ID: 25228541
[TBL] [Abstract][Full Text] [Related]
58. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.
Zuo L; Fan Y; Wang F; Gu Q; Xu X
Curr Eye Res; 2010 May; 35(5):375-84. PubMed ID: 20450250
[TBL] [Abstract][Full Text] [Related]
59. Investigation the effect of
Yılmaz U; Kaya H; Turan M; Bir F; Şahin B
Cutan Ocul Toxicol; 2019 Dec; 38(4):356-359. PubMed ID: 31137972
[No Abstract] [Full Text] [Related]
60. The potential protective effects of miR-497 on corneal neovascularization are mediated via macrophage through the IL-6/STAT3/VEGF signaling pathway.
Wang Y; Gao Y; Huang Y; Pan Y; Yu Y; Zhou Y; Wan SS; Yang YN
Int Immunopharmacol; 2021 Jul; 96():107745. PubMed ID: 33984719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
